| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.6 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |